Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
516 Leser
Artikel bewerten:
(2)

CompuMed, Inc.: CompuMed Expands Cardiology Services to Rural and Regional Hospitals, Revolutionizing Patient Care

LOS ANGELES, CA / ACCESSWIRE / March 12, 2024 / CompuMed, a pioneer in remote diagnostic services for the Organ Donation and Transplant Industry, is now extending its cutting-edge Echo and ECG interpretation services to rural and regional hospitals. This strategic addition comes after decades of dedicated service and a growing demand from healthcare facilities seeking to enhance their cardiology care with rapid, accurate, and HIPAA-compliant diagnostics.

With an established reputation for excellence in the Organ Procurement Organization (OPO) sector, CompuMed's expansion is a response to numerous requests from hospitals across the country. These institutions sought CompuMed's expertise to overcome challenges associated with cardiology reads, which often resulted in delayed patient care due to waiting for study results.

CompuMed's service offerings include the delivery of Echo and ECG study interpretations directly into hospitals' EMR systems, with turnaround times as fast as 30 minutes for stat and guaranteed within 24 hours for standard requests. This efficiency not only improves patient velocity but also ensures timely, in-hospital care that can dramatically enhance patient satisfaction and outcomes.

A current customer of a smaller hospital, praised CompuMed's impact, stating, "What has CompuMed done for us? I'll say it in one word - Speed." The client further highlighted the transformative nature of CompuMed's services: "It used to take anywhere from 2-4 days to get a read back, and now they're always back in under 24 hours, delivered right to our PACS, and into the hands of our doctors. Simple, easy, fast, and always clinically accurate."

By integrating CompuMed's services, hospitals are able to retain more revenue, reduce the need for patient transfers" allow physicians to spend more valuable time with their patients while improving workforce elasticity, and provide their communities with significantly improved healthcare. This advancement represents a major leap forward in making specialized cardiology care accessible to more patients, especially in underserved areas.

About CompuMed

CompuMed brings decades of experience in delivering remote diagnostic solutions to the healthcare industry. With a focus on innovation and patient care, CompuMed's mission is to bridge the gap in medical services through technology, ensuring that every patient has access to the highest standards of healthcare, regardless of their location. CompuMed, Inc. (OTCPink: CMPD) Diagnostic Telemedicine services provide patients with the highest level of clinical care.

For more information about CompuMed's services and its impact on rural and regional healthcare, visit www.compumedinc.com.

Contact Information:

Laura Carroll
Chief Operating Officer
CompuMed
310-258-5002
lcarroll@compumedinc.com
www.compumedinc.com

SOURCE: CompuMed



View the original press release on accesswire.com

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2024 ACCESSWIRE
Diesen Artikel auf Deutsch lesen
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.